Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Total Non-Current Liabilities (2020 - 2021)

Protagonist Therapeutics' Total Non-Current Liabilities history spans 2 years, with the latest figure at $43.4 million for Q3 2021.

  • For Q3 2021, Total Non-Current Liabilities fell 8.76% year-over-year to $43.4 million; the TTM value through Sep 2021 reached $43.4 million, down 8.76%, while the annual FY2020 figure was $44.7 million, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q3 2021 was $43.4 million at Protagonist Therapeutics, down from $46.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $57.4 million in Q2 2020 and bottomed at $38.6 million in Q1 2021.